Works matching IS 03407004 AND DT 2013 AND VI 62 AND IP 4
Results: 18
Properties of monocytes generated from haematopoietic CD34 stem cells from bone marrow of colon cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 705, doi. 10.1007/s00262-012-1375-5
- By:
- Publication type:
- Article
Zoledronic acid-induced expansion of γδ T cells from early-stage breast cancer patients: effect of IL-18 on helper NK cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 677, doi. 10.1007/s00262-012-1368-4
- By:
- Publication type:
- Article
Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 639, doi. 10.1007/s00262-012-1366-6
- By:
- Publication type:
- Article
BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 787, doi. 10.1007/s00262-012-1382-6
- By:
- Publication type:
- Article
Acknowledgement.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 823, doi. 10.1007/s00262-013-1409-7
- Publication type:
- Article
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 773, doi. 10.1007/s00262-012-1384-4
- By:
- Publication type:
- Article
Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 727, doi. 10.1007/s00262-012-1378-2
- By:
- Publication type:
- Article
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 747, doi. 10.1007/s00262-012-1381-7
- By:
- Publication type:
- Article
Impaired immunomodulatory function of chronic myeloid leukemia cancer stem cells and the possible mechanism involved in it.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 689, doi. 10.1007/s00262-012-1367-5
- By:
- Publication type:
- Article
TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4CD25 Treg apoptosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 653, doi. 10.1007/s00262-012-1370-x
- By:
- Publication type:
- Article
Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 737, doi. 10.1007/s00262-012-1380-8
- By:
- Publication type:
- Article
Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 615, doi. 10.1007/s00262-012-1359-5
- By:
- Publication type:
- Article
Enhancement of the anti-melanoma response of Hu14.18K322A by αCD40 + CpG.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 665, doi. 10.1007/s00262-012-1372-8
- By:
- Publication type:
- Article
The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 761, doi. 10.1007/s00262-012-1377-3
- By:
- Publication type:
- Article
Functional human Th17 clones with WT1-specific helper activity.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 801, doi. 10.1007/s00262-012-1385-3
- By:
- Publication type:
- Article
Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 715, doi. 10.1007/s00262-012-1373-7
- By:
- Publication type:
- Article
Combined blockade of TIM-3 and TIM-4 augments cancer vaccine efficacy against established melanomas.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 629, doi. 10.1007/s00262-012-1371-9
- By:
- Publication type:
- Article
Inhibition of both BRAF and MEK in BRAF mutant melanoma restores compromised dendritic cell (DC) function while having differential direct effects on DC properties.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 4, p. 811, doi. 10.1007/s00262-012-1389-z
- By:
- Publication type:
- Article